alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Term ID

CHEBI:61636

Synonyms

(Gal)2 (Glc)1 (GlcNAc)1 (Neu5Ac)1
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulonosyl-(2->3)-beta-D-galactosyl-(1->4)-[beta-D-glucosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucosyl-(1->3)-beta-D-galactose
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranose
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[beta-D-Glc-(1->6)]-beta-D-GlcNAc-(1->3)-beta-D-Gal
Group B Streptococcus Type III Pentasaccharide (Y-shape frameshift)
N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-[beta-D-glucosyl-(1->6)]-N-acetyl-beta-D-glucosaminyl-(1->3)beta-D-galactose
Neu5Acalpha2-3Galbeta1-4(Glcbeta1-6)GlcNAcbeta1-3Galbeta

Definition

A branched amino pentasaccharide comprising the linear sequence α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal with an additional β-D-Glc residue attached to the GlcNAc at the 6-position.

References

glygen:G31709QL
glytoucan:G31709QL
kegg.glycan:G02948
pubmed:32058627

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Phenotype affecting alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp

Human Disease Model